A study to evaluate effect of Phalatrikadi Kashaya Granules and lifestyle modification in obese and non diabetic patients who are and are not having derannged lipid profile

A Randomised Controlled Clinical Study in Non Diabetic Patients to evaluate the effect of Phaltrikadi Kashaya Granules and Life style Modifications in Medoroga w.s.r. to Obesity With and Without Dyslipidemia - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112905

Enrollment

100

Registered

2026-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the trial. Non diabetic patients between the age group of 20-60 years of either gender will be selected for the study. Group I Patients with Serum lipid profile Serum Cholesterol more than 200 mg per dl Serum Triglycerides more than 150 mg per dl Serum LDL more than 100 mg per dl Serum VLDL more than 30 mg per dl Serum HDL less than 40 mg per dl (male) less than 50 mg per dl (female) Fasting Blood Sugar less than 126 mg per dl Hb1AC less than 6 Group I & II Body Mass Index greater than 30 kg per m square Skin fold thickness (With Digital Vernier Clipper) Biceps Triceps Supra iliac Waist circumference (Tape measurement) Men more than 102cm (40 inches) Women more than 88 cm (35 inch) Waist hip ratio more than 1 for men more than 0.85 for women Non Diabetic Patients those who fulfill only the assessment criteria of obesity will be taken.

Exclusion criteria

Exclusion criteria: Patients not falling under inclusion criteria will be excluded.

Design outcomes

Primary

Measure	Time frame
To check the efficacy of Phaltrikadi Kashaya Granules and life style management in Medoroga w.s.r to Obesity and Dyslipidemia in non diabeticTimepoint: 84 days	—

Secondary

Measure	Time frame
To assess the clinical safety in non diabetic patients with Phaltrikadi Kashaya Granules & life style management in Medoroga w.s.r to Obesity & Dyslipidemia .Timepoint: 84 days	—

Countries

India

Contacts

Public ContactDr Sunil Kumar

Rajiv Gandhi Government Post Graduate Ayurvedic College & Hospital Paprola Distt. Kangra 176115

dr.skumarthakur@gmail.com9816195001

Outcome results